The efficacy of rituximab in adult frequently relapsing minimal change disease

BACKGROUND: Corticosteroids are the basis of treatment for nephrotic syndrome due to minimal change disease (MCD), but 25% of patients have frequently relapsing nephrotic syndrome (FRNS) and 30% become steroid dependent. Prolonged use of conventional immunosuppressants causes significant toxicity. R...

Descripción completa

Detalles Bibliográficos
Autores principales: King, Catherine, Logan, Sarah, Smith, Stuart W., Hewins, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
B-Cell Depletion in Glomerulopathies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469552/
https://www.ncbi.nlm.nih.gov/pubmed/28638601
http://dx.doi.org/10.1093/ckj/sfw100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469552/
https://www.ncbi.nlm.nih.gov/pubmed/28638601
http://dx.doi.org/10.1093/ckj/sfw100

Ejemplares similares